Kalyan Roy: A Critical Safety Intervention in Transfusion Medicine
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
”Irradiation of Blood Components
A Critical Safety Intervention in Transfusion Medicine
Purpose (Why Irradiation is Essential)
Prevents Transfusion-Associated Graft-versus-Host Disease (TA-GVHD) TA-GVHD is: Rare but almost universally fatal Associated withmore than 90% mortality rate Caused by:
Viable donor T-lymphocytes Engraftment in recipient and lead to immune-mediated tissue destruction
Pathophysiology of TA-GVHD Donor immunocompetent T-cells survive in recipient circulation Recipient (often immunocompromised) cannot eliminate these cells Donor T-cells:
Recognize recipient tissues as foreign Initiate cell-mediated immune attack Target organs: Skin Liver Gastrointestinal tract Bone marrow
Mechanism of Irradiation Utilizes: Gamma radiation or X-ray irradiation Action: Causes DNA damage in donor T-lymphocytes Prevents cellular proliferation and clonal expansion Outcome: Eliminates risk of TA-GVHD while preserving RBC/platelet function
What Irradiation Does NOT Do
- Does not sterilize blood products
- Does not replace leukoreduction
- Does not affect ABO/Rh compatibility
- Does not prevent all transfusion-related complications
Indications (Who Requires Irradiated Blood)
High-Risk Groups: Immunocompromised patients: Hematology/Oncology cases
- Chemotherapy recipients
- Hematopoietic Stem Cell Transplant (HSCT)
- patients Congenital immunodeficiency disorders
Special Clinical Situations:
- Intrauterine transfusion (IUT)
- Neonatal exchange transfusion / selected neonatal cases
- Directed donations from first-degree relatives
Key Risk Factor:
HLA similarity leads to reduced immune recognition, which increases the risk of transfusion-associated graft-versus-host disease (TA-GVHD).
Key Considerations in Practice Irradiation should be:
Indication-based, not routine Applied with clinical judgment and protocol adherence
Balance is Critical:
- Overuse: Decreased RBC shelf life increased Potassium leakage (risk of hyperkalemia) Increased storage lesion
- Underuse: Risk of fatal TA-GVHD Irreversible clinical consequences
Blood Bank and Clinical Perspective Not just a technical process leads to a governance decision Requires: Proper patient identification Clear communication between clinician and blood bank Reflects: Precision medicine in transfusion practice
Core Message Irradiation is a silent safeguard in transfusion medicine – often unnoticed, but critical in preventing catastrophic outcomes.
Take-Home Points TA-GVHD is rare but highly fatal and Preventable Irradiation causes targeted T-cell inactivation Right patient selection is a Life-saving decision Improper dose leads to either toxicity or fatal risk.”
Other posts featuring Kalyan Roy on Hemostasis Today.
-
Apr 20, 2026, 15:31Tzu-Fei Wang: Drug–Drug Interactions Between DOACs and Prostate Cancer Therapies
-
Apr 20, 2026, 15:30Abinash Choudhury: A Mother’s Advocacy Transforming Hemophilia Care in Nigeria
-
Apr 20, 2026, 15:23Bruno Lacombe: Experiencing a “A Life in a Day” with Hemophilia in Japan
-
Apr 20, 2026, 15:20Eman Hassan: New Insight into AF and VTE at BSH 2026
-
Apr 20, 2026, 15:12Tushar Pandey: From ITP to TTP in Clinical Practice
-
Apr 20, 2026, 15:03Wolfgang Miesbach: The Most Underappreciated Challenges in Haemophilia Care Tackled at WFH 2026
-
Apr 20, 2026, 15:03Danielle Boyle: Patient Voices Transform Progress in ITP Research and Care with ISTH
-
Apr 20, 2026, 14:48Melissa Hollo: Intravenous Iron Shows Better Results Than Oral Iron in Pregnancy
-
Apr 20, 2026, 14:46Annalisa Paviglianiti: Real-World Outcomes of Maribavir for CMV After Hematopoietic Cell Transplantation